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Abstract
Background: Cardiac surgery-associated acute kidney injury (CSA-AKI) contributes to increased morbidity and
mortality. However, its pathophysiology remains incompletely understood. We hypothesized that intra-operative
mean arterial pressure (MAP) relative to pre-operative MAP would be an important predisposing factor for CSA-AKI.
Methods: We performed a prospective observational study of 157 consecutive high-risk patients undergoing
cardiac surgery with cardiopulmonary bypass (CPB). The primary exposure was delta MAP, defined as the pre-
operative MAP minus average MAP during CPB. Secondary exposure was CPB flow. The primary outcome was early
CSA-AKI, defined by a minimum RIFLE class - RISK. Univariate and multivariate logistic regression were performed
to explore for association between delta MAP and CSA-AKI.
Results: Mean (± SD) age was 65.9 ± 14.7 years, 70.1% were male, 47.8% had isolated coronary bypass graft
(CABG) surgery, 24.2% had isolated valve surgery and 16.6% had combined procedures. Mean (± SD) pre-operative,
intra-operative and delta MAP were 86.6 ± 13.2, 57.4 ± 5.0 and 29.4 ± 13.5 mmHg, respectively. Sixty-five patients
(41%) developed CSA-AKI within in the first 24 hours post surgery. By multivariate logistic regression, a delta
MAP≥26 mmHg (odds ratio [OR], 2.8; 95%CI, 1.3-6.1, p = 0.009) and CPB flow rate ≥54 mL/kg/min (OR, 0.2, 0.1-0.5,
p < 0.001) were independently associated with CSA-AKI. Additional variables associated with CSA-AKI included use
of a side-biting aortic clamp (OR, 3.0; 1.3-7.1, p = 0.012), and body mass index ≥25 (OR, 4.2; 1.6-11.2, p = 0.004).
Conclusion: A large delta MAP and lower CPB flow during cardiac surgery are independently associated with early
post-operative CSA-AKI in high-risk patients. Delta MAP represents a potentially modifiable intra-operative factor for
development of CSA-AKI that necessitates further inquiry.
Introduction
Acute kidney injury (AKI) following cardiac surgery with
cardiopulmonary bypass (CPB) can be a devastating
complication associated with high morbidity, mortality
and resource utilization [1,2]. The incidence of cardiac
surgery-associated AKI (CSA-AKI) has ranged between
5-30% [3,4]. This variability is largely attributable to the
numerous definitions applied in prior studies and
assessment of inconsistent at-risk patient populations.
Severe AKI prompting initiation of renal replacement
therapy (RRT) after cardiac surgery is uncommon, how-
ever, has been associated with a 7.9 fold increased risk
of death [5]. However, even relatively mild rises in
serum creatinine in the immediate post-operative period
have been associated with reduced survival [6].
Despite the deleterious impact of CSA-AKI on out-
come, its pathophysiology remains incompletely under-
stood. The extracorporeal circuit and CPB have been
implicated as key contributing factors [7,8]. In parti-
cular, pre-existing chronic kidney disease (CKD),
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been found to predict CSA-AKI [9,10]. In general, how-
ever, there is a paucity of data that has focused on the
association between specific intra-operative CPB para-
meters and risk of CSA-AKI [11].
Accordingly, we performed a prospective observational
study of patients undergoing cardiac surgery with CPB
at high-risk for CSA-AKI. Our objective was to evaluate
for associations between intra-operative CPB parameters
and early post-operative CSA-AKI. Specifically, we
examined the effect of: 1) delta mean arterial pressure
(MAP); and 2) CPB flow on the risk for early post-
operative CSA-AKI.
Methods
Study Design
This was a prospective observational cohort study. Con-
secutive patients undergoing cardiac surgery with CPB
at the Mazankowski Alberta Heart Institute, University
of Alberta Hospital in Edmonton, Canada between July
1, 2008 and October 31, 2008 were screened for enroll-
ment. The cardiac surgery program has eight surgeons
who perform approximately 1400 open heart cases with
CPB per year. The Health Research Ethics Board at the
University of Alberta approved the protocol prior to
commencement.
Study Population
Patients with features putting them at risk for CSA-AKI
were recruited for this study. For this study, patients
deemed “high-risk” w e r ea d o p t e df r o mT h a k a re ta l
[ 1 2 - 1 4 ]a n di n c l u d e dp a t i e n t sw h oh a da tl e a s to n eo f
the following: age ≥70 years; insulin-dependent diabetes
mellitus (DM); congestive heart failure or documented
LVEF <35%; New York Heart Association (NYHA)
symptom severity class 3 or 4; pre-operative serum crea-
tinine ≥106 μmol/L; valve surgery only; valve surgery +
CABG or complex surgery; and/or previous cardiac sur-
gery. Inclusion criteria were adult patients (age ≥18
years) undergoing cardiac surgery with CPB and pre-
sence of at least 1 high-risk criterion. Exclusion criteria
included: planned off-pump cardiac surgery; cardiac or
lung transplantation; isolated ventricular device inser-
tion; and end-stage kidney disease (CKD class V) or
prior kidney transplantation.(Figure 1)
Study Definitions
Acute kidney injury (AKI) was defined using the RIFLE
classification scheme where the three strata of injury
were defined as: i) RISK - serum creatinine increase ×1.5
baseline or urine output <0.5 ml/kg/hour × 6 hours, ii)
INJURY - serum creatinine increase ×2.0 or urine output
<0.5 ml/kg/hour × 12 hours, and iii) FAILURE - serum
creatinine ×3.0 or urine output <0.3 ml/kg/hour × 24
hours or anuria for 12 hours [15]. We ascertained for
AKI within the first 24 post-operative hours after cardiac
surgery. The rationale for this “early” definition was to
capture AKI most likely attributable to intra-operative
factors such as CPB, rather than factors in the post-
operative period. Delta MAP was defined as baseline
MAP (acquired from three independent pre-operative
blood pressure readings) minus the average MAP on
CPB (calculated as the average of MAP readings at
15 minute intervals during CPB).
Study Protocol
For those patients enrolled, detailed data collection was
performed. All data were extracted using standardized
case-report forms and entered into a central Access
2003 database (Microsoft Corp, Richmond, USA). Data
extracted included: demographics (e.g. age, sex, pre-
morbid illness, pre-operative medications), pre-operative
kidney function, surgical details (e.g. coronary bypass,
value replacement, technique, cross-clamp time), intra-
operative parameters (e.g. mean perfusion pressure,
flow, concomitant ultrafiltration, temperature, hemato-
crit, transfusions, use of vasoactive medication, use of
anti-fibrinolytics) and post-operative details (e.g. clinical,
physiologic and laboratory data). Data were also ascer-
tained on clinical outcomes including: occurrence of
AKI, receipt of RRT, duration of mechanical ventilation,
lengths of stay and hospital mortality. Postoperative data
was collected for 5 days. Pre-operative MAP was calcu-
lated as an average of three distinct measurements of
blood pressure separated by greater than 24 hours
between readings. Two of the measurements were con-
ducted preoperatively using an automated blood-pres-
sure cuff (pre-admission clinic and on admission to the
hospital), the third was extracted from anesthesiologist’s
record prior to administration of anesthesia from the
radial arterial line.
Operation and CPB
All surgeries were performed through a midline sternot-
o m yw i t ht h eu s eo fC P B .C P Bw a si n s t i t u t e du s i n g
standard techniques with cannulation of the right atrium
with a 42F cavoatrial venous cannula and the ascending
aorta with a 20 or 22F aortic cannula. In the case of
mitral valve surgery a bicaval cannulation technique
with a 30F SVC- and 34F IVC-cannula was employed
for venous drainage. A phosphorylcholin coated mem-
brane oxygenator (Dideco 903 Avant™) and roller pump
(Stöckert S-3 or S-5, Stöckert Instrument GmbH,
Munich, Germany) was used in all patients. The phos-
phorylcholin coated (PHISIO™, Dideco, Mirandola, Italy)
circuit was primed with Plasma-Lyte® 500 ml, Penta-
span® 500 ml, Mannitol 25 g and 10000 units of unfrac-
tionated heparin (UH). Permissive hypothermia was
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and maintained at >33°C.
UH (400 units/kg) was given prior to cannulation.
Activated clotting time was maintained at ≥480 seconds
during the procedure. Nonpulsatile pump flow rates
were kept at 2.4 L/min/m
2 and the MAP was adjusted
to keep the surgical field bloodless and to avoid severe
hypotension <50 mmHg. In general the targeted MAP
was 60 mmHg. To maintain the filling volume of the
extracorporeal circuit, colloids (Pentaspan®) and Ringer’s
Lactate solution were added. When the hemoglobin was
less than 70 g/L, packed red blood cells were transfused.
Blood cardioplegia with modified Buckberg solution at a
ratio of 4:1 with high potassium (20 mmol/L) at induc-
tion, and at a ratio of 16:1 with low potassium (8 mmol/
L) for maintenance was used for myocardial protection.
Cardioplegic solution was delivered in an antegrade
fashion via the aortic root or by direct cannulation of
t h ec o r o n a r yo s t i ao ri nar e t r o g r a d ef a s h i o nv i at h e
coronary sinus. Heparin was reversed with protamine
following decannulation.
Patients were transferred to the cardiovascular surgical
intensive care unit post-operatively. All fluid, inotropes,
hemodynamics and lab values including creatinine were
recorded for 5 days post-operatively. Post-operative
patient management included radial arterial pressure
monitoring and in some cases thermodilution pulmon-
ary artery catheters (Baxter Healthcare Corp, Santa Ana,
USA) to measure cardiac index. Patients were extubated
from mechanical ventilation at the discretion of the
intensivist according to standard weaning protocols. All
procedure specific data is reported on Table 1.
Statistical Analysis
The primary outcome was incidence of CSA-AKI,
defined by fulfillment of a minimum RIFLE class -
RISK. Patient demographic, clinical, physiologic and
laboratory data for the pre- and intra-operative periods
were summarized as means (± SD) or medians (intra-
quartile ranges [IQR]), and numbers or proportions and
compared using Wilcoxon rank tests, t-tests and chi-
square tests, as appropriate. In the event of missing data
values, data were not replaced or estimated. We evalu-
ated delta MAP and CPB flow both as continuous vari-
ables and dichotomized using an outcome-oriented cut-
off method. Delta MAP, selected clinical factors (i.e. age,
sex) and additional factors found significant by univari-
ate analysis (p < 0.2) were candidates for multivariable
logistic regression. The model was evaluated for coli-
nearity. The final parsimonious model was based on
clinical and statistically significant variables. Model fit
was assessed by the Hosmer and Lemeshow goodness-
of-fit test (c-statistic). Data are presented as odds
ratios (OR) with 95% confidence intervals (CI). P-value
< 0.05 was considered statistically significant for all
comparisons.
Figure 1 Patient Flow Chart.
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Of the 226 patients screened, 157 fulfilled eligibility cri-
teria (Figure 1). Sixty-five patients (41%) developed
CSA-AKI within in the first 24 hours post-surgery.
Table 1 displays the details of patient baseline demo-
graphics and clinical characteristics prior to CPB. Those
patients developing CSA-AKI were more likely to have
insulin-dependent DM (21.5% vs. 8.7%, p = 0.02) and a
higher mean body mass index (BMI) than in the non-
AKI group (31.5 vs. 26.3, p < 0.0001). There was no sig-
nificant difference in preoperative medications, including
operative day administration, between the two groups.
Delta MAP, CPB Flow and CSA-AKI
A summary of intra-operative parameters stratified by
AKI are presented in Table 2. No patient received apro-
tinin. By univariate analysis, average delta MAP was not
significantly different between AKI and non-AKI groups
(28.0 ± 13.2 mmHg vs. 31.3 ± 13.8 mmHg, p = 0.10).
However, in multivariate analysis, expressing delta MAP
as a continuous variable, every one percent increase in
delta MAP, significantly increased the odds of AKI
increased by 3% after adjustment of other covariates
(OR 1.03, 1.0-1.07, p = 0.05, C-statistic = 0.783). More-
over, for patients with a delta MAP ≥26 mmHg, there
was a 2.1-fold (95% CI, 1.1-4.2, p = 0.024) increased
odds for CSA-AKI (Table 3). A delta MAP ≥26 mmHg
was found to be independently associated with CSA-
AKI in multi-variable analysis (OR 2.8; 95% CI, 1.3-6.1,
p = 0.009, Table 4).
A higher CPB flow rate was associated with lower odds
of CSA-AKI. Univariate analysis demonstrated that CPB
flow in the non-AKI group was significantly higher (60.9
ml/kg/min vs. 55.5 ml/kg/min, OR 0.2; 95% CI, 0.1-0.5,
p < 0.01) (Tables 2 and 3). By multivariable analysis, an
average blood flow on CPB is ≥54 ml/kg/min was asso-
ciated with a significantly lower odds of CSA-AKI (OR
0.3; 95% CI, 0.1-0.7, p = 0.004, Table 4). In addition, in
this model, both a BMI ≥25 kg/m
2 and use of an intra-
operative side-biting clamp were independently asso-
ciated with greater odds of CSA-AKI (Table 4). In the
second multivariable model with delta MAP as a continu-
ous variable, both BMI as a continuous variable (OR 1.2;
95% CI, 1.1-1.3, p < 0.0001) and use of a side-biting
clamp (OR 2.4; 95% CI, 1.04-5.8, p = 0.039) remained
independently associated with higher odds of AKI.
No other intra-operative factors were significantly
associated with early CSA-AKI. Specifically, no differ-
ences were noted by number of coronary bypass grafts,
type of surgery preformed, and duration of either aortic
cross clamp or CPB.
Sensitivity Analysis
A sensitivity analysis was conducted using a different
validated definition of AKI (creatinine increase of greater
than 25% or 44.2 μmol/L). This sensitivity multivariable
model, after adjusting for confounders, showed similar
independent associations between delta MAP, CPB flow,
use of side-biting clamp and elevated BMI and develop-
ment of post-operative CSA-AKI (Additional file 1).
The peak delta serum creatinine over the first 5 post-
operative days was 22.9 μmol/L (+/- 27.2). When stratified
by a delta MAP, the peak delta serum creatinine values
Table 1 Baseline demographic and pre-operative
characteristics stratified by post-operative CSA-AKI
Characteristic No AKI (n =
92)
AKI (n =
65)
p-
value
Age (years) (mean[± SD]) 64.7 ± 15.8 67.5 ± 13 0.33
Male Sex (%) 64 (69.6) 46 (70.8) 0.87
BMI (kg/m
2) (mean[± SD]) 26.3 ± 4.1 31.5 ± 7.1 <
0.0001
CAD (%) 42 (45.7) 38 (58.5) 0.11
Angina (%) 8 (8.7) 5 (7.7) 0.83
Previous MI 35 (38) 31 (47.7) 0.23
Previous Revascularization (%) 9 (9.8) 4 (6.2) 0.42
Valve disease (%) 52 (56.5) 27 (41.5) 0.06
HTN (%) 51 (55.4) 44 (67.7) 0.12
DM - Insulin-Dependent (%) 8 (8.7) 14 (21.5) 0.02
DM - Non Insulin Dependent
(%)
23 (25) 24 (36.9) 0.12
Dyslipidemia (%) 57 (62) 48 (73) 0.12
PVD (%) 9 (9.8) 11 (16.9) 0.19
CVD (%) 9 (9.8) 5 (7.7) 0.65
Creatinine (μmol/L) (mean[±
SD])
102.1 ± 29.3 100.3 ±
24.1
0.98
Chronic Kidney Disease (%) 12 (13) 9 (13.8) 0.88
Pre-op SBP (mm Hg) (mean [±
SD])
123.6 ± 21.1 129.5 ±
20.9
0.07
Pre-op DBP (mm Hg) (mean [±
SD])
66.5 ± 13.3 67.4 ± 13.3 0.66
Pre-op MAP (mm Hg) (mean [±
SD])
85.5 ± 13.2 88.1 ± 13.2 0.22
EF (%)(mean [± SD]) 48.4 ± 13.2 47.5 ± 13.6 0.55
ASA (%) 76 (82.6) 54 (83.1) 0.90
Clopidogrel (%) 12 (13.0) 9 (13.8) 0.88
Beta-Blocker (%) 62 (67.5) 45 (69.2) 0.81
CCB (%) 17 (18.5) 11 (16.9) 0.08
ACE inhibitor (%) 56 (60.9) 31 (47.7) 0.10
ARB (%) 6 (6.5) 3 (4.6) 0.62
Statin (%) 60 (65.2) 46 (70.3) 0.46
Loop Diuretic (%) 34 (37) 28 (43.1) 0.44
Thiazide (%) 35 (38) 31 (47.7) 0.23
Spironolactone (%) 2 (2.2) 4 (6.2) 0.23
Abbreviations: DM = diabetes mellitus; BMI = body mass index; AKI = acute
kidney injury; CAD = Coronary artery disease, HTN = Hypertension, PVD =
peripheral vascular disease, CVD = cerebro-vascular disease, EF = ejection
fraction, ASA = acetylsalicylic acid, CCB = Calcium channel blocker, ACE =
Angiotensin converting enzyme, ARB = Angiotensin receptor blocker
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and 20.3 μmol/L (+/- 28.4) delta MAP <26 mmHg.
Clinical Outcomes and CSA-AKI
Post-operative outcomes, including time on mechanical
ventilation, length of ICU stay were similar between
those with and without CSA-AKI (Table 5). No patient
received acute RRT and all patients survived to hospital
discharge.
Discussion
We performed a prospective observational study of 157
cardiac surgery patients receiving cardiopulmonary
bypass at elevated risk for CSA-AKI to evaluate the
impact of intra-operative variables, specifically delta
MAP and CPB flow, on the development of early post-
operative CSA-AKI.
We found early post-operative AKI was common,
occurring in 41% of patients. While this would appear
significantly higher than prior studies, our study was
focused on patients at higher risk for CSA-AKI. In two
observational studies of CSA-AKI, defined by the RIFLE
criteria, the post-operative incidence of CSA-AKI ranged
3.7-9%(16, 17). In addition, we found that a delta MAP
≥26 mmHg was independently associated with develop-
ment of early CSA-AKI. More specifically, every 1%
increase in delta MAP was found to be associated with
a3 %h i g h e rr i s ko fC S A - A K I .W ef o u n dt h a tC P B
Table 2 Summary of intra-operative variables stratified by post-operative CSA-AKI
Variable No AKI (n = 92) AKI (n = 65) p-value
Valve only surgery (%) 26 (28.3) 12 (18.5) 0.16
Combined (valve + CABG) (%) 43 (46.7) 21 (32.3) 0.07
Re-operation (%) 8 (8.7) 6 (9.2) 0.91
# Grafts (mean [± SD]) 3.4 ± 1.1 3.5 ± 1.1 0.77
Duration of CPB (min, mean [± SD]) 126.6 ± 52 127.2 ± 63.2 0.69
Duration of cross clamp (min, mean [± SD]) 90.9 ± 46.9 88.7 ± 57.1 0.42
Average CPB MAP (mmHg, mean [± SD]) 57.8 ± 5.1 56.9 ± 4.9 0.25
Minutes <MAP 60 mmHg (median [± IQR]) 59 ± 65 56 ± 45 0.49
Minutes <MAP 50 mmHg (median [± IQR]) 2.5 ± 10 5.0 ± 15 0.35
Delta MAP (mmHg, mean [± SD]) 28.0 ± 13.2 31.3 ± 13.8 0.10
PRBC transfusions (units, mean [± SD]) 1.8 ± 1.5 2.4 ± 2.3 0.27
Patients transfused with PRBC (%) 23 (25) 19 (29.2) 0.56
Insulin dose (Units, mean [± SD]) 3.3 ± 1.3 3.6 ± 3.1 0.72
Furosemide dose (mg, n = 9, n = 7, mean [± SD]) 22.8 ± 10.3 27.1 ± 12.5 0.50
Ultrafiltration (mL, n = 34, n = 25, mean [± SD]) 1440 ± 1049 1470 ± 1344 0.98
Received tranexamic acid (%) 83 (90.2) 58 (89.2) 0.84
Received aprotinin (%) 0 (0) 0 (0) NS
Use of side-biting clamp (%) 16 (17.4) 21 (32.2) 0.03
Average flow (mL/kg/min, mean[± SD]) 60.9 ± 7.1 55.5 ± 8.4 0.001
Average temperature (°C, mean [± SD]) 35.3 ± 1.4 35.5 ± 1.1 0.75
Abbreviations: AKI = acute kidney injury; CABG = coronary artery bypass graft, CPB = cardiopulmonary bypass; MAP = mean arterial pressure; PRBC = packed red
blood cell
Table 3 Univariate Factors associated with early CSA-AKI
Predictor Odds
Ratio
95% CI P-value
Male Sex 1.06 0.5-2.1 0.87
Age (per year) 1.01 0.99-
1.04
0.25
Age ≥ 75 years (present) 1.7 0.8-3.5 0.15
BMI (kg/m
2)(per 1 point) 1.2 0.8-3.5 <
0.0001
BMI ≥25 kg/m
2 (present) 4.4 1.9-10.2 0.0007
Valve disease (present) 0.55 0.3-1.0 0.06
DM (present) 2.2 1.1-4.2 0.025
PVD (present) 1.9 0.9-3.3 0.19
HTN (present) 1.7 0.9-3.3 0.12
Delta MAP (per 1 mmHg) 1.02 0.99-
1.04
0.14
Delta MAP ≥26 mmHg (present) 2.1 1.1-4.2 0.024
Flow ≥54 per mL/kg/min (present) 0.2 0.1-0.5 0.0002
pH 1.4 0.8-2.7 0.26
Pre-operative ACE inhibitor (present) 0.6 0.3-1.1 0.1
Valve Surgery (present) 0.5 0.3-1 0.07
Peak CPB-MAP 0.5 0.2-0.97 0.04
Pre-operative Systolic BP (≥111
mmHg)
2.1 0.99-4.6 0.05
Duration of CPB MAP ≤60 (per 1 min) 1.99 0.9-4.4 0.89
Abbreviations: BMI = Body Mass Index; DM = Diabetes Mellitus PVD =
Peripheral Vascular Disease; HTN = Hypertension; MAP = Mean Arterial
Pressure; ACE = Angiotensin Converting Enzyme; CPB=Cardiopulmonary
Bypass’ MAP = mean arterial pressure
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ciated with higher risk of early post-operative AKI. We
also found that higher BMI (> 25 kg/m
2) and the intra-
operative use of a side-biting aortic clamp were asso-
ciated with higher risk of early post-operative AKI.
While we used the relatively sensitive RIFLE criteria to
define AKI, we also found these results were robust
when defining CSA-AKI as an increase in creatinine of
>25% or >44.2 μmol/L in sensitivity analysis.
By identifying a high-risk cohort we were able to pro-
spectively evaluate important and potentially modifiable
peri-operative factors [12]. A recent analysis of the
RIFLE criteria was conducted by Kuitunen et al [18],
which showed that patients undergoing cardiac surgery
fulfilling AKI-R criteria (the definition employed in this
study) have an 8% 30-day mortality rate compared to
0.9% in the non-risk population. A similar phenomenon
was shown by Dasta et al, using the same AKI
definition, who reported that even minor elevations of
creatinine in the AKI-R group was associated with 2.2
fold greater mortality, 1.6 fold greater ICU length of
stay and 1.6 fold greater post operative costs when com-
pared to controls [17]. In light of this data we have
focused not on clinical outcomes, but on the immediate
post-operative period, to study the influence of delta
MAP and CPB flow as contributing factors to the devel-
opment of CSA-AKI.
Our study is the first to specifically examine the
impact of delta MAP, or patient-specific relative hypo-
tension, on peri-operative risk of CSA-AKI. We demon-
strate that in addition to a fractional increase in delta-
MAP,ad r o pi nM A P≥26 mmHg from preoperative
baseline blood pressure is associated 2.8 times greater
risk for the development of CSA-AKI. An absolute pro-
longed drop in pressure <60 mmHg has previously been
identified as risk factor for CSA-AKI [7,19]. Further-
more, poorer neurological outcomes and end-organ per-
fusion have been associated with CPB pressures <60
mm Hg [20]. The role of relative hypotension during
CPB remains debated and data exists to suggest that
absolute hypotension while on CPB alone is not asso-
ciated with the development of CSA-AKI [21]. Despite
the ongoing discussion on role of perfusion pressure,
there is a convincing data to suggest that increased CPB
duration has deleterious effects on kidney function and
promotes injury [1,10,22]. Unfortunately the majority of
the studies that report on CPB duration did not include
CPB hemodynamics, specifically CPB-MAP, in the ana-
lysis and none of the studies evaluate the change relative
to pre-operative pressures (i.e. delta MAP) [1,22]. We
Table 4 Multi-variable adjusted logistic regression
model
¶ of association between delta MAP and CSA-AKI
Parameter Odds Ratio 95% CI P-value
Male sex 0.7 0.3-1.7 0.49
Age ≥75 years (present) 2.1 0.9-4.9 0.08
BMI ≥25 kg/m
2 (present) 4.2 1.6-11.2 0.0039
Delta MAP ≥26 mmHg (present) 2.8 1.3-6.1 0.009
Flow ≥54 per mL/kg/min (present) 0.3 0.1-0.7 0.004
Side-biting clamp (present) 3.0 1.3-7.1 0.012
Abbreviations: BMI = Body Mass Index; MAP = mean arterial pressure; CPB =
cardiopulmonary bypass
Model characteristics: C-statistic = 0.788
Table 5 Summary of post-operative clinical outcomes
No AKI (n = 92) AKI (n = 65) p-value
ICU Duration (hours) (median [IQR]) 53 (19-87) 65 (30-100) 0.86
Ventilation duration (hours, median [IQR]) 15 (8-22) 15 (6-24) 0.48
RRT (%) 0 0 NS
Death (%) 0 0 NS
Creatinine baseline (μmol/L, mean [± SD]) 102.1 ± 29.3 100.3 ± 24.1 0.98
Creatinine Day 1 (μmol/L, mean [± SD]) 107.6 ± 31.4 114.3 ± 27.1 0.03
Creatinine Day 2 (μmol/L, mean [± SD]) 109.4 ± 37.0 121.4 ± 35.5 0.003
Creatinine Day 3 (μmol/L, mean [± SD]) 101.4 ± 32.9 116.5 ± 40.4 0.0003
Creatinine Day 4 (μmol/L, mean [± SD]) 97.1 ± 32.9 111.8 ± 45.5 0.011
Creatinine Day 5 (μmol/L, mean [± SD]) 97.6 ± 29.6 115.3 ± 44.5 0.02
Creatinine peak 5-day difference (μmol/L, mean [± SD]) 16.53 ± 17.68 31.69 ± 34.88 0.002
Urine Output 12 hours (ml/kg/hr, mean [± SD]) 1.3 ± 0.6 0.8 ± 0.4 0.002
Urine Output 24 hours (ml/kg/hr, mean [± SD]) 1.0 ± 0.8 0.5 ± 0.5 < 0.0001
Urine Output 36 hours (ml/kg/hr, mean [± SD]) 1.1 ± 0.8 1.0 ± 0.7 0.02
Urine Output 48 hours (ml/kg/hr, mean [± SD]) 1.1 ± 0.7 0.8 ± 0.5 0.38
Highest MAP 5 days post op (mean [± SD]) 97.1 ± 13.0 95 ± 12.9 0.25
Lowest MAP in 5 days post-op (mean [± SD]) 67.6 ± 9.1 64.6 ± 7.3 0.07
Abbreviations: ICU = intensive care unit, RRT = renal replacement therapy
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tive complications defined as composite outcome of car-
diac death, CHF, or rise in SCr >20% with a relative
drop in intra-operative blood pressure >20 mmHg or
20% [23]. A recent study by Aronson et al demonstrated
that pre-operative hypertension with an increase in
pulse pressure is an independent risk factor for AKI
[24]. Our study would argue that hypertension might be
a surrogate marker for a greater relative drop in CPB
MAP, which might contribute to CSA-AKI.
The literature has examples of studies that refute CPB
hypotension as an independent risk factor for CSA-AKI,
however, these studies are generally small, observational,
underpowered, and more importantly, these studies
failed to investigate the impact of hypotension as a func-
tion of pre-operative baseline MAP [20,25-27]. The
notion of relative hypotension or delta-MAP induced
end-organ injury has been recently shown. Gottesman et
al found that patients with greater drops of MAP on
CPB relative to pre-operative MAP had poorer neurolo-
gical outcomes [28]. Furthermore, Lombardi et al
demonstrated that lower MAP during CPB was an inde-
pendent risk factor in the development of CSA-AKI [8].
This study suggested low CPB MAP is a potentially
important determinant for CSA-AKI, however, does not
correlate duration of hypotension to pre-operative base-
line. In addition, the study showed a difference of only
0.5 mmHg between cohorts, which though statistically
different, may have limited clinical relevance. Though
Lomabrdi et al suggest that hypotension during CPB in
general could have deleterious effect on post-operative
kidney function, our study has shown that the magni-
tude of injury may be more a function of the degree of
hypotension relative to pre-operative baseline MAP.
Cardiopulmonary pressure and flow are intimately
related and both are important to preserve end organ
perfusion. Currently, there is controversy regarding the
superiority of CPB flow delivered as pulsatile or non-
pulsatile [29]. Surprisingly, there is paucity in the litera-
ture describing the effect of flow on CSA-AKI. Those
studies describing the effect of CPB flow on post-opera-
tive complications, by in large, focus on neurological
outcomes after cardiac surgery [30,31]. Our study identi-
fies CPB flow as an independent factor associated with
increasing the likelihood of post-operative CSA-AKI.
We found that higher flow rates may be protective and
associated with prevention of CSA-AKI.
Many theories surrounding the initiation of inflamma-
tory pathways to hemodynamics, in particular CPB
hypotension and flow have been proposed with little
supporting evidence [25,32]. CPB related practices, in
particular perfusion pressure and flow, are by in large
founded on empirical practices and lack the scientific
basis to serve as evidence-based guidelines [11,33]. The
literature surrounding pump hemodynamics and effect
on physiology and clinical outcomes is surprisingly
scarce, in particular relating to CSA-AKI. Our study
suggests that there should be a concerted effort in re-
evaluating strategies surrounding CPB practices and
influence on CSA-AKI. Our findings suggest that main-
taining a delta MAP <26 mm Hg may be important dur-
ing CPB to prevent CSA-AKI. Increasing the perfusion
pressure can be accomplished by either elevating sys-
temic vascular resistance pharmacologically (which may
theoretically reduce renal perfusion) or by increasing
CBP flow. As we found the latter to also be protective
against CSA-AKI, we would suggest that this be consid-
ered first; however, we also caution that confirmatory
studies are needed.
Our study has notable limitations. Firstly, our study is
single centered, relatively small and observational in nat-
ure making it prone to bias. Not being able to control
for interventions may have resulted in patients who
were deemed high-risk to be maintained intra-opera-
tively at a higher MAP. Secondly, our study may have
been subjected to a selection bias, for example a certain
surgeon may be more apt to operate on more compli-
cated and higher risk patients with different intra-opera-
tive practices. Thirdly, the small sample and relatively
sensitive definition for AKI used in our study, coupled
with a short post-operative study period, largely limited
our statistical power and precluded us from detecting
potentially meaningful differences in clinical outcomes,
such as duration of mechanical ventilation, duration of
I C Us t a ya n dn e e df o rR R T .A sa f o r e m e n t i o n e d ,t h i s
was in part intended, in order to isolate as best as possi-
ble the impact of intra-operative hemodynamic variables
on risk of post-operative CSA-AKI. We attempted to
control for available confounders by applying an a priori
selection criteria and collection of factors that could
contribute to CSA-AKI. These factors were included in
multivariable analysis. Finally, we recognize for the
aforementioned reasons, our single-centre study of
patients undergoing cardiac surgery with CPB at higher
risk for CSA-AKI has limited overall generalizability,
when taken in context to patients at lower risk for CSA-
AKI or those receiving cardiac surgery at other institu-
tions or in other jurisdictions.
In summary, despite the above mentioned limitations,
our study is the first prospective study to focus on the
association between delta MAP and post-operative CSA-
AKI. A large delta MAP and lower CPB flow are indepen-
dently associated with development of early post-opera-
tive CSA-AKI in patients with prior high-risk features.
These factors are potentially identifiable and modifiable.
We contend these factors require further investigation.
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Additional file 1: Sensitivity multi-variable analysis exploring the
association of delta MAP and CPB flow rate on post-operative CSA-
AKI using an alternative definition for CSA-AKI.
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